Development of fluorescence-linked immunosorbent assay for high throughput screening of interferon-γ

Allergology International

Volumn 55, Issue 1, 2006, Pages 49-54

  Matsukuma, Eiji ^a   Kato, Zenichiro ^a   Omoya, Kentaro ^a   Hashimoto, Kazuyuki ^a   Li, Ailian ^a   Yamamoto, Yutaka ^a   Ohnishi, Hidenori ^a   Hiranuma, Hidenori ^b   Komine, Hisakazu ^b   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

^b Applied Biosystems Japan Ltd   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Fluorescence linked immunosorbent assay; Fluorometric microvolume assay technology; High throughput screening; Interferon gamma

Indexed keywords

ALLOPHYCOCYANIN; GAMMA INTERFERON; HUMAN INTERFERON; INTERLEUKIN 18 BINDING PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IC 50; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 33645774948     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.49     Document Type: Article

References (28)

1. Kelso A. Cytokines and their receptors;an overview. Ther. Drug Monit. 2000;22:40-43.
2. Zhu H, Yang J, Murphy TL et al. Unexpected characteristics of the IFN-gamma reporters in non-transformed T cells. J. Immunol. 2001;167:855-865.
3. Tran EH, Prince EN, Owens T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 2000;164:2759-2768.
4. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997;15:749-795.
5. Ohnishi H, Kato Z, Watanabe M et al. Interleukin-18 is associated with the severity of atopic dermatitis. Allergol. Int. 2003;52:123-130.
6. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001;12:53-72.
7. Shikano H, Kato Z, Kaneko H et al. IFN-gamma production in response to IL-18 or IL-12 stimulation by peripheral blood mononuclear cells of atopic patients. Clin. Exp. Allergy 2001;31:1263-1270.
8. Kondo N, Matsui E, Kaneko H et al. Genetic defects in downregulation of IgE production and a new genetic classification of atopy. Allergol. Int. 2004;53:77-85.
9. Swartzman EE, Miraglia SJ, Mellentin-Michelotti J, Evangelista L, Yuan PM. A homogeneous and multiplexed immunoassay or high-throughput screening using fluorometric microvolume assay technology. Anal. Biochem. 1999;271:143-151.
10. Kato Z, Jee J, Shikano H et al. The structure and binding mode of interleukin-18. Nat. Struct. Biol. 2003;10:966-971.
11. Omoya K, Kato Z, Matsukuma E et al. Systemic optimization of active protein expression using GFP as a folding reporter. Protein Expr. Purif. 2004;36:327-332.
12. Li A, Kato Z, Ohnishi H et al. Optimized gene synthesis and high expression of human interleukin-18. Protein Expr. Purifi. 2003;32:110-118.
13. Konishi K, Tanabe F, Taniguchi M et al. A simple and sensitive bioassay for the detection of human interleukin-18/interferon-γ-inducing factor using human myelomonocytic KG-1 cells. J. Immunol. Methods 1997;209:187-191.
14. Wu C, Sakorafas P, Miller R et al. IL-18 receptor beta-induced changes in the presentation of IL-18 binding sites affect ligand binding and signal transduction. J. Immunol. 2003;170:5571-5577.
15. Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new cytokine that induces IFN-γ production by T-cells. Nature 1995;378:88-91.
16. Ushio S, Namba M, Okura T et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic actives of the protein. J. Immunol. 1996;156:4274-4279.
17. Oliver DG, Sanders AH, Hogg RD, Hellman JW. Thermal gradients in microtitration plates. Effects on enzyme-linked immunoassay. J. Immunol. Methods 1981;42:195-201.
18. Shekarchi IC, Sever JL, Lee YJ, Castellano G, Madden DL. Evaluation of various plastic microtiter plates with measles, toxoplasma, and gamma globulin antigens in enzyme-linked immunosorbent assays. J. Clin. Microbiol. 1984;19:89-96.
19. Matthieu S, Bruce MR, Sharmistha D et al. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc. Natl. Acad. Sci. U. S. A. 2003;100:7354-7359.
20. Morokata T, Ida K, Yamada T. Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. Int. Immunopharmacol. 2004;4:873-883.
21. Komatsu N, Shichijo S, Maeda Y, Itoh K. Measurement of interferon-γ by high-throughput fluorometric microvolume assay technology system. J. Immunol. Methods 2002;263:169-176.
22. Brejc K, Ficner R, Huber R, Steinbacher S. Isolation, crystallization, crystal structure analysis and refinement of allophycocyanin from the cyanobacterium Spirulina platensis at 2.3A resolution. J. Mol. Biol. 1995;249:424-440.
23. Ölschläger P, Srikant-lyer S, Lange S, Schmitt J, Schmid RD. Fluorophor-linked immunosorbent assay;a time- and cost-saving method for the characterization of antibody fragments using a fusion protein of a single-chain antibody fragment and enhanced green fluorescent protein. Anal. Biochem. 2002;309:27-34.
24. Dietz LJ, Dubrow RS, Manian BS, Sizto NL. Volumetric capillary cytometry;a new method for absolute cell enumeration. Cytometry 1996;23:177-186.
25. Melletin-Michelotti J, Evangelista LT, Swartzman EE, Miraglia SJ, Werner WE, Yuan PM. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. Anal. Biochem. 1999;272:182-190.
26. Martens C, Bakker A, Rodriguez A et al. A generic particle-based nonradioactive homogeneous multiplex method for high-throughput screening using microvolume fluorometry. Anal. Biochem. 1999;273:20-31.
27. Miraglia S, Swartman EE, Mellentin-Michelotti J et al. Homogeneous cell- and bead-based assays for high throughput screening using fluorometric microvolume assay technology. J. Biomol. Screen 1999;4:193-204.
28. Lee JY, Miraglia S, Yan X et al. Oncology drug discovery applications using the FMAT 8100 HTS system. J. Biomol. Screen 2003;8:81-88.